CCL Biomedical Inc.

Company Information

Company Name
CCL Biomedical Inc.
Address
224 N. Washington Street
Havre de Grace, MD, -
Phone
1 410-939-9356
URL
n/a
DUNS
91905484
Number of Employees
2
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$519,602.00
5
SBIR Phase II
$463,713.00
1
STTR Phase I
$99,977.00
1
STTR Phase II
$500,000.00
1
Chart code to be here

Award List

  1. STTR Phase I: Engineering of Non-leaching Antibacterial Surfaces and Textiles

    Amount: $99,977.00

    This Small Business Technology Transfer (STTR) Phase I proposes to develop antibacterial surfaces and textiles for commercial applications. A series of novel potent dendrimer biocides has been identi ...

    STTR Phase I 2003 National Science Foundation
  2. Anti-Terrorism- Consequence Management and Recovery

    Amount: $69,991.00

    The threat of terrorist or military attack using biological, chemical or radiological weapons is one of the largest concerns to U.S. military forces. Development of defense initiatives that can be imp ...

    SBIR Phase I 2003 NavyDepartment of Defense
  3. STTR Phase II: Engineering of Non-leaching Antibacterial Non-woven Textiles

    Amount: $500,000.00

    This Small Business Technology Transfer (STTR) Phase II project proposes the development of a unique family of biocidal polymers that have been shown to be non-leaching, and do not require regenerati ...

    STTR Phase II 2006 National Science Foundation
  4. Polymers for Infection Resistant Urinary Catheters

    Amount: $99,995.00

    DESCRIPTION (provided by applicant): Hospital acquired infections are on the increase and compromise the quality and cost-effectiveness of health care. A significant number of device-associated inf ...

    SBIR Phase I 2003 Department of Health and Human Services
  5. SBIR Phase I: Biocidal Textiles for Active Infection Control

    Amount: $100,000.00

    This Small Business Innovation Research (SBIR) Phase I project aims to develop a novel antimicrobial compound to provide active infection control to textiles that will be applied as a finishing treatm ...

    SBIR Phase I 2007 National Science Foundation
  6. Biocidal Surfaces for Medical Hardware

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Each year, 5-10% of patients admitted to acute care hospitals in the United States (1.75- 3.5 million people) acquire an infection while in hospital. Consequences ...

    SBIR Phase I 2008 Department of Health and Human Services
  7. SBIR Phase II: Biocidal Textiles for Active Infection Control

    Amount: $463,713.00

    This Small Business Innovation Research Phase II project focuses on the development of patented antimicrobial compounds to provide superior infection control to textiles. 5-10% of patients admitted to ...

    SBIR Phase II 2009 National Science Foundation
  8. High Performance Antimicrobial Textiles

    Amount: $149,616.00

    The goal of this Phase I SBIR proposal is to develop and evaluate a new antimicrobial coating to augment infection control in medical care settings. Laboratory and clinical studies have shown that bac ...

    SBIR Phase I 2013 Department of Defense

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government